156P Efficacy and safety of a novel nanosomal docetaxel lipid suspension (NDLS) as an anti cancer agent - a retrospective study
Gespeichert in:
Veröffentlicht in: | Annals of oncology 2016-12, Vol.27 (suppl_9) |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | suppl_9 |
container_start_page | |
container_title | Annals of oncology |
container_volume | 27 |
creator | Ashraf, M. Sajjad, R. Khan, M.A. Shah, M. Bhat, Y. Wani, Z.A. |
description | |
doi_str_mv | 10.1093/annonc/mdw579.008 |
format | Article |
fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdw579_008</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdw579_008</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1338-36da0160ba4a67bd5d747707b66f4a70ab606b109d09a03d09c37612b8307a4e3</originalsourceid><addsrcrecordid>eNotkE1LAzEQhoMoWKs_wFuOeth20uwmu0ep9QOKCup5mc2HRLZJ2aTVPfnXjVQYZmB452F4CLlkMGPQ8Dl6H7yab_RXJZsZQH1EJqwSTVFDyY7JBJoFL2TFy1NyFuMnAIhm0UzITw690JW1TqEaKXpNI1qTRhosRerD3vTUow8xbLCnOiiT8Dvverd1ObuLW-OjC55ePd2uX68pxgzJlRxV6JUZKH4Yn2iRaYNJQ8gHKrm9oTHt9HhOTiz20Vz8zyl5v1u9LR-K9fP94_JmXSjGeV1woRGYgA5LFLLTlZallCA7IWyJErATILpsQkODwHNXXAq26GoOEkvDp4QduCp_EAdj2-3gNjiMLYP2z2B7MNgeDLbZIP8Fuztm0w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>156P Efficacy and safety of a novel nanosomal docetaxel lipid suspension (NDLS) as an anti cancer agent - a retrospective study</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Ashraf, M. ; Sajjad, R. ; Khan, M.A. ; Shah, M. ; Bhat, Y. ; Wani, Z.A.</creator><creatorcontrib>Ashraf, M. ; Sajjad, R. ; Khan, M.A. ; Shah, M. ; Bhat, Y. ; Wani, Z.A.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdw579.008</identifier><language>eng</language><ispartof>Annals of oncology, 2016-12, Vol.27 (suppl_9)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1338-36da0160ba4a67bd5d747707b66f4a70ab606b109d09a03d09c37612b8307a4e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Ashraf, M.</creatorcontrib><creatorcontrib>Sajjad, R.</creatorcontrib><creatorcontrib>Khan, M.A.</creatorcontrib><creatorcontrib>Shah, M.</creatorcontrib><creatorcontrib>Bhat, Y.</creatorcontrib><creatorcontrib>Wani, Z.A.</creatorcontrib><title>156P Efficacy and safety of a novel nanosomal docetaxel lipid suspension (NDLS) as an anti cancer agent - a retrospective study</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNotkE1LAzEQhoMoWKs_wFuOeth20uwmu0ep9QOKCup5mc2HRLZJ2aTVPfnXjVQYZmB452F4CLlkMGPQ8Dl6H7yab_RXJZsZQH1EJqwSTVFDyY7JBJoFL2TFy1NyFuMnAIhm0UzITw690JW1TqEaKXpNI1qTRhosRerD3vTUow8xbLCnOiiT8Dvverd1ObuLW-OjC55ePd2uX68pxgzJlRxV6JUZKH4Yn2iRaYNJQ8gHKrm9oTHt9HhOTiz20Vz8zyl5v1u9LR-K9fP94_JmXSjGeV1woRGYgA5LFLLTlZallCA7IWyJErATILpsQkODwHNXXAq26GoOEkvDp4QduCp_EAdj2-3gNjiMLYP2z2B7MNgeDLbZIP8Fuztm0w</recordid><startdate>20161201</startdate><enddate>20161201</enddate><creator>Ashraf, M.</creator><creator>Sajjad, R.</creator><creator>Khan, M.A.</creator><creator>Shah, M.</creator><creator>Bhat, Y.</creator><creator>Wani, Z.A.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20161201</creationdate><title>156P Efficacy and safety of a novel nanosomal docetaxel lipid suspension (NDLS) as an anti cancer agent - a retrospective study</title><author>Ashraf, M. ; Sajjad, R. ; Khan, M.A. ; Shah, M. ; Bhat, Y. ; Wani, Z.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1338-36da0160ba4a67bd5d747707b66f4a70ab606b109d09a03d09c37612b8307a4e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ashraf, M.</creatorcontrib><creatorcontrib>Sajjad, R.</creatorcontrib><creatorcontrib>Khan, M.A.</creatorcontrib><creatorcontrib>Shah, M.</creatorcontrib><creatorcontrib>Bhat, Y.</creatorcontrib><creatorcontrib>Wani, Z.A.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ashraf, M.</au><au>Sajjad, R.</au><au>Khan, M.A.</au><au>Shah, M.</au><au>Bhat, Y.</au><au>Wani, Z.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>156P Efficacy and safety of a novel nanosomal docetaxel lipid suspension (NDLS) as an anti cancer agent - a retrospective study</atitle><jtitle>Annals of oncology</jtitle><date>2016-12-01</date><risdate>2016</risdate><volume>27</volume><issue>suppl_9</issue><issn>0923-7534</issn><eissn>1569-8041</eissn><doi>10.1093/annonc/mdw579.008</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0923-7534 |
ispartof | Annals of oncology, 2016-12, Vol.27 (suppl_9) |
issn | 0923-7534 1569-8041 |
language | eng |
recordid | cdi_crossref_primary_10_1093_annonc_mdw579_008 |
source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
title | 156P Efficacy and safety of a novel nanosomal docetaxel lipid suspension (NDLS) as an anti cancer agent - a retrospective study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A17%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=156P%20Efficacy%20and%20safety%20of%20a%20novel%20nanosomal%20docetaxel%20lipid%20suspension%20(NDLS)%20as%20an%20anti%20cancer%20agent%20-%20a%20retrospective%20study&rft.jtitle=Annals%20of%20oncology&rft.au=Ashraf,%20M.&rft.date=2016-12-01&rft.volume=27&rft.issue=suppl_9&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdw579.008&rft_dat=%3Ccrossref%3E10_1093_annonc_mdw579_008%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |